CortiSlim® StudyResults Presented

CortiSlim® StudyResults Presented

ATHENS, GreeceThe results of astudy on the impact of CortiSlim® on weight loss and mood elevation werepresented during the 5th International Conference on Nutrition & Fitness,held here.

Shawn Talbott, Ph.D., conducted a 12-week, double blind,placebo-controlled clinical study to evaluate the effect of CortiSlim (suppliedby Window Rock Health Laboratories, Yorba Linda, Calif.) on measures ofstress/mood, cortisol, body weight and body composition.

Fifty subjects were recruited from among volunteers who hadtried and failed to lose weight on other diet programs, or who had lost weightand regained it within the last year. The subjects consumed two CortiSlimcapsules per day or placebo. Those receiving CortiSlim (www.cortislim.com) lostnine times as much weight as the control group and had twice the fat loss andinches lost from the mid-section. In addition, subjects taking CortiSlim had a15 percent improvement in overall mood and a 20 percent reduction in cortisollevels.